Rankings
▼
Calendar
CAMP FY 2019 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena
CAMP
CAMP4 Therapeutics Corporation
$125M
FY 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$366M
+0.6% YoY
Gross Profit
$143M
39.1% margin
Operating Income
-$17M
-4.6% margin
Net Income
-$79M
-21.5% margin
EPS (Diluted)
$-2.34
Cash Flow
Operating Cash Flow
$12M
Free Cash Flow
-$10M
Stock-Based Comp.
$11M
Balance Sheet
Total Assets
$496M
Total Liabilities
$358M
Stockholders' Equity
$138M
Cash & Equivalents
$107M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$366M
$364M
+0.6%
Gross Profit
$143M
$148M
-3.0%
Operating Income
-$17M
$20M
-185.1%
Net Income
-$79M
$18M
-528.2%
← FY 2018
All Quarters
Q1 2019 →